Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.48 |
| ▸ | MME | P08473 | 5/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | QRFPR | Q96P65 | 2/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | GNPAT | O15228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31488806 | 1.00 | TGFBR1 (0.48) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL8542259 | 1.00 | TGFBR1 (0.48) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL29819412 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL455811 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL29385234 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL31651029 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL19283433 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL19283432 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL1229828 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 | |
| SCHEMBL1229824 | 0.98 | TGFBR1 (0.47) | TGFBR1MMETERTCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9136 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116148467-B | Complete reagent for detecting interaction between post-translational modification protein and ligand thereof | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260125489-A1 | ANTI-LEWIS Y ANTIBODY AND PRO-ANTIBODY THEREOF | GLYCONEX INC (TW) | 2026-05-07 | — | — | US | claimed |
| EP-4705440-A1 | NAMPT FUSION PROTEINS | Monash University (AU) | 2026-03-11 | — | — | EP | claimed |
| EP-4678664-A2 | ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY PERMEATING BLOOD-BRAIN BARRIER | JCR Pharmaceuticals Co., Ltd. (JP) | 2026-01-14 | — | — | EP | claimed |
| EP-3315606-B1 | ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY PERMEATING BLOOD-BRAIN BARRIER | JAPAN CHEM RES (JP) | 2025-11-26 | — | — | EP | claimed |
| EP-4653533-A1 | HUMAN TRANSFERRIN RECEPTOR-AVID PEPTIDE | JCR Pharmaceuticals Co., Ltd. (JP) | 2025-11-26 | — | — | EP | claimed |
| US-20250333481-A1 | FUSION PROTEIN OF SERUM ALBUMIN AND PHYSIOLOGICALLY-ACTIVE PROTEIN | JCR PHARMACEUTICALS CO., LTD. (JP) | 2025-10-30 | — | — | US | claimed |
| US-20250282878-A1 | COMPOSITIONS AND METHODS FOR MODULATING ANTIGEN BINDING ACTIVITY | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2025-09-11 | — | — | US | claimed |
| EP-4603587-A1 | FUSION PROTEIN OF SERUM ALBUMIN AND PHYSIOLOGICALLY-ACTIVE PROTEIN | JCR Pharmaceuticals Co., Ltd. (JP) | 2025-08-20 | — | — | EP | claimed |
| EP-3436006-B1 | METHODS AND COMPOSITIONS FOR MODULATING FRATAXIN EXPRESSION | WISCONSIN ALUMNI RES FOUND (US) | 2025-07-30 | — | — | EP | claimed |
| WO-2022045273-A1 | MUTANT OF α-N-ACETYLGLUCOSAMINIDASE | ＪＣＲファーマ株式会社 | 2022-03-03 | — | — | WO | claimed |
| WO-2022023963-A1 | DEVELOPMENT OF A NEW ENGINEERED TOBACCO ETCH VIRUS (TEV) PROTEASE ACTIVABLE IN THE CYTOSOL OR SECRETORY PATHWAY | Università Cattolica del Sacro Cuore (IT) | 2022-02-03 | — | — | WO | claimed |
| CN-111856024-B | Method for detecting interaction between biological membrane proteins and kit used in method | 清华大学 | 2022-01-28 | — | — | CN | claimed |
| CN-113956348-A | Glucagon and GLP-1 co-agonist compounds | 伊莱利利公司 | 2022-01-21 | — | — | CN | claimed |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-10-15 | — | — | US | claimed |
| EP-2925771-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | Council of Scientific & Industrial Research (IN) | 2015-10-07 | — | — | EP | claimed |
| WO-2014083578-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESERACH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2014-06-05 | — | — | WO | claimed |
| US-5750555-A | NERVOUS SYSTEM DISORDERS; SKIN DISORDERS; IMMUNOLOGY | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1998-05-12 | — | — | US | claimed |
| EP-0674632-A1 | AMINOACID DERIVATIVES OF HETEROCYCLES AS PROTEIN KINASE C INHIBITORS | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1995-10-04 | — | — | EP | claimed |
| WO-1994014798-A1 | AMINOACID DERIVATIVES OF HETEROCYCLES AS PROTEIN KINASE C INHIBITORS | Gödecke Aktiengesellschaft (DE) | 1994-07-07 | — | — | WO | claimed |